Hikma Pharmaceutical | HIK - Net Income

Hikma Pharmaceutical reported $15M in Net Income for its second fiscal semester of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Net Income Change
Artemis Alpha ATS:LN GBP -26769000 16.52M
AstraZeneca AZN:LN USD 901M 739M
Bayer BAYN:GR EUR 611M 65M
Fresenius FRE:GR EUR 255M 67M
Fresenius Medical Care FMS:US EUR 139M 91.1M
Genmab GEN:DC DKK 584M 2B
GlaxoSmithKline GSK:LN GBP 1.5B 8.82B
Hikma Pharmaceutical HIK:LN USD 15M 158M
Merck MRK:GR EUR 654M 269M
Orion ORNBV:FH EUR 31.7M 162.8M
Recordati REC:IM EUR 90.05M 35.37M
Roche Holding ROG:VX 3.89B 4.64B